Sato, Masakazu
Sato, Sho
Shintani, Daisuke
Hanaoka, Mieko
Ogasawara, Aiko
Miwa, Maiko
Yabuno, Akira
Kurosaki, Akira
Yoshida, Hiroyuki
Fujiwara, Keiichi
Hasegawa, Kosei
Article History
Received: 11 July 2021
Accepted: 22 December 2021
First Online: 13 January 2022
Declarations
:
: All human-related methods were carried out in accordance with relevant guidelines and regulations. The study was approved by the Institutional Review Board of Saitama Medical University International Medical Center (approval no. 13-165). Tumor specimens were available from the patients who underwent surgery for primary ovarian cancer with their informed consent in the previous study (no. 12-096). Written informed consent from each patient was obtained.
: Written informed consent for publication from each patient was obtained in the previous study (no. 12-096).
: The authors declare that they have no competing interests.